Gleicher, Norbert
Darmon, Sarah
Molinari, Emanuela
Zhang, Lin
Hu, Jianjun
Albertini, David F.
Barad, David H.
Article History
Received: 18 May 2020
Accepted: 23 September 2020
First Online: 2 October 2020
Compliance with ethical standards
:
: Drs. Gleicher and Barad are listed as co-inventors on a number of U.S. patents. Some of these patents relate to pre-supplementation of hypo-androgenic infertile women with androgens, such as DHEA and testosterone and, therefore, relate to the subject of this manuscript. N.G., D.F.A, and D.H.B. have received research support, travel funds and speaker honoraria from a number of pharmaceutical and medical device companies, though none related to here presented subjects and manuscript. Dr. Gleicher is a shareholder in Fertility Nutraceuticals, LLC. Drs. Gleicher and Barad receive royalty payments from Fertility Nutraceuticals LLC. That company’s over-the-counter products (DHEA and CoQ10) were used in this study.